Back to Journals » Drug Design, Development and Therapy » Volume 17
Original Research
Efficacy and Prognostic Factors of Regorafenib in the Treatment of BCLC Stage C Hepatocellular Carcinoma After Failure of the First-Line Therapy
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
3,416 | Dovepress* | 3,222+ | 77 | 3,299 | |
PubMed Central* | 194 | 90 | 284 | ||
Totals | 3,416 | 167 | 3,583 | ||
*Since 16 February 2023 |
View citations on PubMed Central and Google Scholar